A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk for several adverse outcomes among patients with diabetic kidney disease. Yet, optimal timing for SGLT2i after acute kidney injury (AKI) is uncertain, as are the providers responsible for post-AKI SGLT2i initiation. Using a retrospec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney international 2024-07, Vol.106 (1), p.126-135
Hauptverfasser:	Murphy, Daniel P., Wolfson, Julian, Reule, Scott, Johansen, Kirsten L., Ishani, Areef, Drawz, Paul E.
Format:	Artikel
Sprache:	eng
Schlagworte:	acute kidney injury diuretics sodium-glucose cotransporter-2 inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!